ArticlePharmaceutics2022

Scaffold Repurposing Reveals New Nanomolar Phosphodiesterase Type 5 (PDE5) Inhibitors Based on Pyridopyrazinone Scaffold: Investigation of In Vitro and In Silico Properties.

Kamelia M Amin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.